Cargando…
Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
IN BRIEF Women with type 2 diabetes are less likely to receive prescriptions for contraceptives despite the fact that diabetes is associated with an increased risk of maternal and fetal complications. In the largest case series to date examining use of the levonorgestrel-releasing intrauterine devic...
Autores principales: | Lang, Benjamin, Josephy, Tatiana, Micks, Elizabeth, McCoy, Erin, Prager, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053853/ https://www.ncbi.nlm.nih.gov/pubmed/30078945 http://dx.doi.org/10.2337/cd17-0028 |
Ejemplares similares
-
Perceptions of Anal Intercourse Among Heterosexual Women: A Pilot Qualitative Study
por: Benson, Lyndsey S., et al.
Publicado: (2019) -
Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017) -
Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021) -
Effects of the levonorgestrel‐releasing intrauterine device on the immune microenvironment of the human cervix and endometrium
por: Shanmugasundaram, Uma, et al.
Publicado: (2016) -
Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo
por: Cavrois, Marielle, et al.
Publicado: (2019)